This trial also includes an open-label portion for adults with type 1 diabetes up to 15 years since diagnosis. The open-label portion (n=40) is examining the efficacy, safety, and durability of BMF-219 at two oral dose levels, 100 mg and 200 mg over 12-week treatment followed by a 40-week off treatment period.

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

SPOILER ALERT! This post contains details from Episode 3 of Agatha All Along. Agatha Harkness and her ragtag coven encounter their first obstacle on The Witches Road in Episode 3 of Agatha All Along.